Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
 EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

Volume 11, Number 10, October 2005

Botulinum Neurotoxin Detection and Differentiation by Mass Spectrometry

John R. Barr,* Hercules Moura,* Anne E. Boyer,* Adrian R. Woolfitt,* Suzanne R. Kalb,* Antonis Pavlopoulos,* Lisa G. McWilliams,† Jurgen G. Schmidt,‡ Rodolfo A. Martinez,‡ and David L. Ashley*
*Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Battelle Memorial Institute, Atlanta, Georgia, USA; and ‡Los Alamos National Laboratory, Los Alamos, New Mexico, USA

 
 
Figure 1.
  Back to article
 

Figure 1. Synaptobrevin on the synaptic vesicle must interact with syntaxin and SNAP (synaptosomal-associated protein)-25 on the neuronal membrane for fusion to occur, which allows the nerve impulse to be delivered across the synaptic junction. The botulinum neurotoxin serotypes cleave the peptide bonds at specific sites on the 3 proteins, as indicated. Cleavage of any 1 of these proteins prevents vesicle membrane docking and nerve impulse transmission.

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed August 24, 2005

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention